Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

Peer Review reports

Original Submission
11 Apr 2018	Submitted	Original manuscript
21 May 2018	Reviewed	Reviewer Report - Halima Dawood
4 Jun 2018	Reviewed	Reviewer Report - Mauro Zaccarelli
12 Jun 2018	Author responded	Author comments - Lucia Taramasso
Resubmission - Version 2
12 Jun 2018	Submitted	Manuscript version 2
17 Jun 2018	Reviewed	Reviewer Report - Halima Dawood
2 Jul 2018	Reviewed	Reviewer Report - Mauro Zaccarelli
20 Jul 2018	Author responded	Author comments - Lucia Taramasso
Resubmission - Version 3
20 Jul 2018	Submitted	Manuscript version 3
Publishing
23 Jul 2018	Editorially accepted
31 Jul 2018	Article published	10.1186/s12879-018-3268-5

Back to article page